Hinge Health (NYSE:HNGE) Coverage Initiated by Analysts at Bank of America

Stock analysts at Bank of America assumed coverage on shares of Hinge Health (NYSE:HNGE - Get Free Report) in a research note issued to investors on Monday,Briefing.com Automated Import reports. The firm set a "buy" rating and a $42.00 price target on the stock. Bank of America's price objective suggests a potential upside of 20.83% from the stock's current price.

HNGE has been the subject of a number of other research reports. Wall Street Zen raised shares of Hinge Health to a "hold" rating in a report on Monday, June 2nd. Barclays began coverage on Hinge Health in a report on Monday. They issued an "overweight" rating and a $43.00 price objective on the stock. Canaccord Genuity Group assumed coverage on Hinge Health in a research report on Monday. They set a "buy" rating and a $52.00 target price on the stock. Needham & Company LLC initiated coverage on shares of Hinge Health in a research report on Monday. They set a "buy" rating and a $47.00 price target for the company. Finally, KeyCorp initiated coverage on Hinge Health in a report on Monday. They issued an "overweight" rating and a $45.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $46.00.

Hinge Health Trading Down 0.7%

NYSE:HNGE opened at $34.76 on Monday. Hinge Health has a 12 month low of $33.42 and a 12 month high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.